| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 156.0K | $8.50M | - | |
| CEO | 99.9K | $5.44M | - | |
| CFO | 82.7K | $4.50M | - | |
| VP | 74.4K | $4.05M | - | |
| VP | 69.7K | $3.80M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Swayze Eric63 | EVP Research | Sell | 6,849 | $69.02 | $472,717.98 | -18.4% | +13.8% | - | |
| Oct 6, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 13,441 | $69.74 | $937,337.63 | -10.8% | +13.8% | - | |
| Oct 2, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 64,664 | $67.69 | $4,377,054.43 | -36.1% | +15.7% | - | |
| Oct 2, 2025 | Baroldi Joseph53 | EVP, Chief Business Officer | Sale+OE | 15,000 | $68.01 | $1,020,210.00 | -32.0% | +15.7% | - | |
| Oct 2, 2025 | Swayze Eric63 | EVP Research | Sale+OE | 27,114 | $66.16 | $1,793,744.13 | -26.7% | +15.7% | - | |
| Oct 1, 2025 | Wender Joseph H | Director | Sell | 16,800 | $65.50 | $1,100,384.88 | -15.4% | +20.0% | - | |
| Sep 30, 2025 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 57,900 | $65.24 | $3,777,668.13 | -42.1% | +22.3% | - | |
| Sep 30, 2025 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sale+OE | 49,800 | $65.26 | $3,249,733.86 | -31.1% | +22.3% | - | |
| Sep 30, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 25,300 | $64.62 | $1,634,921.48 | -18.1% | +22.3% | - | |
| Sep 12, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 1,700 | $64.58 | $109,787.19 | -2.9% | +25.3% | - |